1.Z. Ma, J. Yuan, J. Xu, L. Li, C. Tang, L. Chang, R.J. Quinn, L. Qin*, J. Liu*, Y Ye*, Quaternized acridine maleimide MALDI probe enables mass spectrometry imaging of thiols. Anal Chem, 2022, 94(43):14917-14924.
2.Z. Zhu, X. Li, C. Tang, J. Shen, J. Liu*, and Y. Ye*, A derivatization strategy for comprehensive identification of 2- and 3-hydroxyl fatty acids by LC-MS. Anal Chim Acta, 2022, 1216: 339981.
3.D. Zhu, H. Su, C. Ke, C. Tang, M. Witt, R.J. Quinn, Y. Xu*, J. Liu*, and Y. Ye*, Efficient discovery of potential inhibitors for SARS-CoV-2 3C-like protease from herbal extracts using a native MS-based affinity-selection method. J Pharm Biomed Anal, 2022, 209: 114538.
4.F. Lin#, Y. Ma#, A. Pan, Y. Ye, J. Liu*, Quantification of usaramine and its N-oxide metabolite in rat plasma using liquid chromatography-tandem mass spectrometry. J Anal Toxicol, 2022, 46(5): 512-518.
5.L. Chang#, F. Lin#, K. Cheng, J. Li, X. Sun, D. Figeys, J. Jiang, Y. Ye*, J. Liu*. A simultaneous identification and quantification strategy for determination of sulfhydryl-containing metabolites in normal- and high-fat diet hamsters using stable isotope labeling combined with LC-MS. Anal Chim Acta, 2021, 1184: 339016.
6.L. Li, L. Chang, X. Zhang, Z. Ning, J. Mayne, Y. Ye, A. Stintzi, J. Liu*, and D. Figeys*, Berberine and its structural analogs have differing effects on functional profiles of individual gut microbiomes. Gut Microbes, 2020: 1-14.
7.X. Zheng#, H. Duan#, F. Lin#, X. Li, J. Shen, F. Han, F. Huang, S. Li, L. Chang, H. Xu*, K. Wang*, and J. Liu*, Quantification of microbiota-related phenols and aromatic acids in mouse feces of a diabetic nephropathy model by simultaneous BDAPE derivatization using ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem, 2020, 412(13): 3241-3252.
8.H. Fu#, Q. Zhang#, X. Huang#, Z. Ma, X. Zheng, S. Li, H. Duan, X. Sun, F. Lin, L. Zhao, G. Teng*, and J. Liu*, A rapid and convenient derivatization method for quantitation of short-chain fatty acids in human feces by ultra-performance liquid chromatography-tandem mass spectrometry. Rapid Commun Mass Spectrom, 2020: e8730.
9.J. Zhao, Q. Zhang, J.H. Shen, K. Wang*, and J. Liu*, Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy. Acta Pharmacol Sin, 2019. 40(4): 507-513.
10.M. Liu, J. Yuan, W. Hu, C. Ke, Y. Zhang, Y. Ye, D. Zhong, G. Zhao*, S. Yao*, and J. Liu*, Pretreatment with broad-spectrum antibiotics alters the pharmacokinetics of major constituents of Shaoyao-Gancao decoction in rats after oral administration. Acta Pharmacol Sin, 2019. 40(2): 288-296.
11.H. Su#, S. Yao#, W. Zhao#, Y. Zhang#, J. Liu#, Q. Shao#, Q. Wang, M. Li, H. Xie, W. Shang, C. Ke, L. Feng, X. Jiang, J. Shen, G. Xiao, H. Jiang, L. Zhang*, Y. Ye*, and Y. Xu*, Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV2 3CL protease. Nat Commun, 2021. 12(1): 3623.
12.J. Liu, X. Zhou, X. Chen, and D. Zhong, Excretion of [3H]triptolide and its metabolites in rats after oral administration. Acta Pharmacol Sin, 2014. 35(4): 549-54.
13.J. Liu, L. Wang, W. Hu, X. Chen, and D. Zhong, Development of a UHPLC-MS/MS method for the determination of plasma histamine in various mammalian species. J Chromatogr B, 2014. 971: 35-42.
14.J. Liu, L. Li, X. Zhou, X. Chen, H. Huang, S. Zhao, X. Li, and D. Zhong, Metabolite profiling and identification of triptolide in rats. J Chromatogr B, 2013. 939: 51-58.
15.J. Liu, X. Chen, Y. Zhang, H. Miao, K. Liu, L. Li, and D. Zhong, Derivatization of (5R)-hydroxytriptolide from benzylamine to enhance mass spectrometric detection: application to a Phase I pharmacokinetic study in humans. Anal Chim Acta, 2011. 689(1): 69-76.